301 related articles for article (PubMed ID: 28721444)
21. Proton beam therapy leads to excellent local control rates in choroidal melanoma in the intermediate fundus zone.
Schönfeld S; Cordini D; Riechardt AI; Seibel I; Willerding G; Bechrakis NE; Moser L; Joussen AM
Am J Ophthalmol; 2014 Dec; 158(6):1184-91. PubMed ID: 25128597
[TBL] [Abstract][Full Text] [Related]
22. Neoadjuvant proton beam irradiation vs. adjuvant ruthenium brachytherapy in transscleral resection of uveal melanoma.
Böker A; Pilger D; Cordini D; Seibel I; Riechardt AI; Joussen AM; Bechrakis NE
Graefes Arch Clin Exp Ophthalmol; 2018 Sep; 256(9):1767-1775. PubMed ID: 29907945
[TBL] [Abstract][Full Text] [Related]
23. A randomized controlled trial of varying radiation doses in the treatment of choroidal melanoma.
Gragoudas ES; Lane AM; Regan S; Li W; Judge HE; Munzenrider JE; Seddon JM; Egan KM
Arch Ophthalmol; 2000 Jun; 118(6):773-8. PubMed ID: 10865313
[TBL] [Abstract][Full Text] [Related]
24. [Results of proton beam irradiation for treatment of choroidal melanoma].
Lumbroso L; Levy C; Plancher C; Frau E; D'hermies F; Schlienger P; Dendale R; Mammar H; Delacroix S; Nauraye C; Noel G; Ferrand R; Desblancs C; Mazal A; Validire P; Asselain B; Desjardins L
J Fr Ophtalmol; 2002 Mar; 25(3):290-7. PubMed ID: 11941255
[TBL] [Abstract][Full Text] [Related]
25. Outcomes of treatment with stereotactic radiosurgery or proton beam therapy for choroidal melanoma.
Sikuade MJ; Salvi S; Rundle PA; Errington DG; Kacperek A; Rennie IG
Eye (Lond); 2015 Sep; 29(9):1194-8. PubMed ID: 26160531
[TBL] [Abstract][Full Text] [Related]
26. Outcomes of proton radiation therapy for peripapillary choroidal melanoma at the BC Cancer Agency.
Tran E; Ma R; Paton K; Blackmore E; Pickles T
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1425-31. PubMed ID: 22209152
[TBL] [Abstract][Full Text] [Related]
27. Visual outcomes of proton beam therapy for choroidal melanoma at a single institute in the Republic of Korea.
Jung SK; Park YH; Shin DH; Kim HS; Jung JH; Kim TH; Moon SH
PLoS One; 2020; 15(12):e0242966. PubMed ID: 33264363
[TBL] [Abstract][Full Text] [Related]
28. Visual Outcome and Millimeter Incremental Risk of Metastasis in 1780 Patients With Small Choroidal Melanoma Managed by Plaque Radiotherapy.
Shields CL; Sioufi K; Srinivasan A; Di Nicola M; Masoomian B; Barna LE; Bekerman VP; Say EAT; Mashayekhi A; Emrich J; Komarnicky L; Shields JA
JAMA Ophthalmol; 2018 Dec; 136(12):1325-1333. PubMed ID: 30267070
[TBL] [Abstract][Full Text] [Related]
29. Predictors of Neovascular Glaucoma in Central Retinal Vein Occlusion.
Rong AJ; Swaminathan SS; Vanner EA; Parrish RK
Am J Ophthalmol; 2019 Aug; 204():62-69. PubMed ID: 30862502
[TBL] [Abstract][Full Text] [Related]
30. Anterior segment sparing to reduce charged particle radiotherapy complications in uveal melanoma.
Daftari IK; Char DH; Verhey LJ; Castro JR; Petti PL; Meecham WJ; Kroll S; Blakely EA
Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):997-1010. PubMed ID: 9392537
[TBL] [Abstract][Full Text] [Related]
31. Proton beam irradiation of uveal melanoma involving the iris, ciliary body and anterior choroid without surgical localisation (light field).
Oxenreiter MM; Lane AM; Aronow MB; Shih H; Trofimov AV; Kim IK; Gragoudas ES
Br J Ophthalmol; 2022 Apr; 106(4):518-521. PubMed ID: 33355171
[TBL] [Abstract][Full Text] [Related]
32. Glaucoma After Iodine-125 Brachytherapy for Uveal Melanoma: Incidence and Risk Factors.
Kim EA; Salazar D; McCannel CA; Kamrava M; Demanes DJ; Lamb J; Caprioli J; McCannel TA
J Glaucoma; 2020 Jan; 29(1):1-10. PubMed ID: 31688338
[TBL] [Abstract][Full Text] [Related]
33. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.
Wakabayashi T; Oshima Y; Sakaguchi H; Ikuno Y; Miki A; Gomi F; Otori Y; Kamei M; Kusaka S; Tano Y
Ophthalmology; 2008 Sep; 115(9):1571-80, 1580.e1-3. PubMed ID: 18440643
[TBL] [Abstract][Full Text] [Related]
34. Ranibizumab for the Prevention of Radiation Complications in Patients Treated With Proton Beam Irradiation for Choroidal Melanoma.
Kim IK; Lane AM; Jain P; Awh C; Gragoudas ES
Trans Am Ophthalmol Soc; 2016 Aug; 114():T2. PubMed ID: 27630373
[TBL] [Abstract][Full Text] [Related]
35. Trabeculectomy in patients with uveal melanoma after proton beam therapy.
Riechardt AI; Cordini D; Rehak M; Hager A; Seibel I; Böker A; Gundlach E; Heufelder J; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2016 Jul; 254(7):1379-85. PubMed ID: 26960442
[TBL] [Abstract][Full Text] [Related]
36. Clinical Features of Ocular Ischemic Syndrome and Risk Factors for Neovascular Glaucoma.
Kim YH; Sung MS; Park SW
Korean J Ophthalmol; 2017 Aug; 31(4):343-350. PubMed ID: 28682017
[TBL] [Abstract][Full Text] [Related]
37. [Neovascular glaucoma following proton-beam therapy. Case report].
D'Hermies F; Meyer A; Morel X; Lumbroso L; Levy C; Desjardins L; Frau E; Halhal M; Elmaleh C; Berges O; Gauthier JB; Ferrand R; Delacroix S; Schlienger P; Schwarz L; Habrand JL; Mazeron A; Renard G
J Fr Ophtalmol; 2001 Jan; 24(1):95-101. PubMed ID: 11240479
[TBL] [Abstract][Full Text] [Related]
38. Radiation-Induced Optic Neuropathy: Observation versus Intravitreal Treatment: Can Visual Acuity Be Maintained by Intravitreal Treatment?
Eckstein D; Riechardt AI; Heufelder J; Zeitz O; Böker A; Brockmann C; Joussen AM; Seibel I
Am J Ophthalmol; 2019 Dec; 208():289-294. PubMed ID: 31323201
[TBL] [Abstract][Full Text] [Related]
39. Proton beam therapy for presumed and confirmed iris melanomas: a review of 36 cases.
Rahmi A; Mammar H; Thariat J; Angellier G; Herault J; Chauvel P; Kodjikian L; Denis P; Grange JD
Graefes Arch Clin Exp Ophthalmol; 2014 Sep; 252(9):1515-21. PubMed ID: 25038910
[TBL] [Abstract][Full Text] [Related]
40. Estimates of ocular and visual retention following treatment of extra-large uveal melanomas by proton beam radiotherapy.
Conway RM; Poothullil AM; Daftari IK; Weinberg V; Chung JE; O'Brien JM
Arch Ophthalmol; 2006 Jun; 124(6):838-43. PubMed ID: 16769837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
